Evidence map›Paper›PMID 33227987›Full record

ArticlePharmaceuticals (Basel, Switzerland)2020

Availability of Guanitoxin in Water Samples Containing

Kelly Afonsina Fernandes, Humberto Gomes Ferraz, Fanny Vereau, Ernani Pinto

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kelly Afonsina FernandesDepartment of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 580, Butantã CEP 05508-900, São Paulo, Brazil.ORCID 0000-0001-9247-4438
Humberto Gomes FerrazDepartment of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 580, Butantã CEP 05508-900, São Paulo, Brazil.
Fanny VereauDepartment of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 580, Butantã CEP 05508-900, São Paulo, Brazil.
Ernani PintoDepartment of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 580, Butantã CEP 05508-900, São Paulo, Brazil.ORCID 0000-0001-7614-3014
Universidade de São Paulo · BR

Funding

Coordination for the Improvement of Higher Education Personnel (CAPES) 23038.001401/2018-92Fundação de Amparo à Pesquiso do Estado de São Paulo (FAPESP) 2014/50420-9National Council for Scientific and Technological Development (CNPq) 311048/2016-1National Council for Scientific and Technological Development (CNPq) 439065/2018-6
6 · The paper itself

Abstract

Guanitoxin (GNT) is a potent neurotoxin produced by freshwater cyanobacteria that can cause the deaths of wild and domestic animals. Through reports of animal intoxication by cyanobacteria cells that produce GNT, this study aimed to investigate the bio-accessibility of GNT in simulated solutions of the gastrointestinal content in order to understand the process of toxicosis promoted by GNT in vivo. Dissolution tests were conducted with a mixture of

Indexed as

anatoxin-a(s)bio-accessibilitycyanobacteria poisoningneurotoxins

Identifiers

PMID33227987
PMCPMC7699232
OpenAlexW3103973889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.